129 related articles for article (PubMed ID: 12846439)
1. NO-aspirin: mechanism of action and gastrointestinal safety.
Fiorucci S; Del Soldato P
Dig Liver Dis; 2003 May; 35 Suppl 2():S9-19. PubMed ID: 12846439
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study.
Fiorucci S; Santucci L; Gresele P; Faccino RM; Del Soldato P; Morelli A
Gastroenterology; 2003 Mar; 124(3):600-7. PubMed ID: 12612897
[TBL] [Abstract][Full Text] [Related]
3. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats.
Fiorucci S; Antonelli E; Santucci L; Morelli O; Miglietti M; Federici B; Mannucci R; Del Soldato P; Morelli A
Gastroenterology; 1999 May; 116(5):1089-106. PubMed ID: 10220501
[TBL] [Abstract][Full Text] [Related]
5. NCX 4040, a nitric oxide-donating aspirin, exerts anti-inflammatory effects through inhibition of I kappa B-alpha degradation in human monocytes.
Ricciotti E; Dovizio M; Di Francesco L; Anzellotti P; Salvatore T; Di Francesco A; Sciulli MG; Pistritto G; Monopoli A; Patrignani P
J Immunol; 2010 Feb; 184(4):2140-7. PubMed ID: 20065114
[TBL] [Abstract][Full Text] [Related]
6. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
[TBL] [Abstract][Full Text] [Related]
7. Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans.
Fiorucci S; Mencarelli A; Meneguzzi A; Lechi A; Renga B; del Soldato P; Morelli A; Minuz P
J Am Coll Cardiol; 2004 Aug; 44(3):635-41. PubMed ID: 15358033
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
9. Dual COX-inhibitors: the answer is NO?
Fiorucci S; Antonelli E
Curr Top Med Chem; 2005; 5(5):487-92. PubMed ID: 15974943
[TBL] [Abstract][Full Text] [Related]
10. NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide.
Fiorucci S; Mencarelli A; Meneguzzi A; Lechi A; Morelli A; del Soldato P; Minuz P
Circulation; 2002 Dec; 106(24):3120-5. PubMed ID: 12473561
[TBL] [Abstract][Full Text] [Related]
11. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Kwiecień S; Pajdo R; Ptak A; Pawlik M; Hahn E
Dig Liver Dis; 2000 Oct; 32(7):583-94. PubMed ID: 11142556
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders.
Gresele P; Momi S
Cardiovasc Drug Rev; 2006; 24(2):148-68. PubMed ID: 16961726
[TBL] [Abstract][Full Text] [Related]
13. Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence.
Fiorucci S; Distrutti E; Mencarelli A; Rizzo G; Lorenzo AR; Baldoni M; Del Soldato P; Morelli A; Wallace JL
J Pharmacol Exp Ther; 2004 Jun; 309(3):1174-82. PubMed ID: 14762100
[TBL] [Abstract][Full Text] [Related]
14. In vitro study of the anti-aggregating activity of two nitroderivatives of acetylsalicylic acid.
Lechi C; Gaino S; Tommasoli R; Zuliani V; Bonapace S; Fontana L; Degan M; Lechi A; Minuz P
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):206-9. PubMed ID: 8735820
[TBL] [Abstract][Full Text] [Related]
15. Vasorelaxant effects of a nitric oxide-releasing aspirin derivative in normotensive and hypertensive rats.
Muscará MN; Lovren F; McKnight W; Dicay M; del Soldato P; Triggle CR; Wallace JL
Br J Pharmacol; 2001 Aug; 133(8):1314-22. PubMed ID: 11498517
[TBL] [Abstract][Full Text] [Related]
16. IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs.
Fiorucci S; Santucci L; Cirino G; Mencarelli A; Familiari L; Soldato PD; Morelli A
J Immunol; 2000 Nov; 165(9):5245-54. PubMed ID: 11046058
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha.
Fiorucci S; Santucci L; Federici B; Antonelli E; Distrutti E; Morelli O; Renzo GD; Coata G; Cirino G; Soldato PD; Morelli A
Aliment Pharmacol Ther; 1999 Mar; 13(3):421-35. PubMed ID: 10102977
[TBL] [Abstract][Full Text] [Related]
18. Effect of aspirin, paracetamol and their nitric oxide donating derivatives on exudate cytokine and PGE2 production in zymosan-induced air pouch inflammation in rats.
Mamuk S; Melli M
Eur J Pharmacol; 2007 Apr; 561(1-3):220-5. PubMed ID: 17320862
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of aspirin and NO-releasing aspirins on differentiation, maturation and function of human monocyte-derived dendritic cells in vitro.
Bufan B; Mojsilović S; Vucićević D; Vucević D; Vasilijić S; Balint B; Colić M
Int Immunopharmacol; 2009 Jul; 9(7-8):910-7. PubMed ID: 19341823
[TBL] [Abstract][Full Text] [Related]
20. Lack of gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in the stomach of diabetic rats.
Tashima K; Fujita A; Umeda M; Takeuchi K
Life Sci; 2000 Aug; 67(13):1639-52. PubMed ID: 10983857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
